The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online

Auravelle Metals commences gold discovery aircore program at Nuckulla Hill

Auravelle Metals has commenced testing new drill targets at the Nuckulla Hill gold project in South…

BPM Minerals granted Bonnie and Clyde drilling approvals

BPM Minerals has received the final key approval allowing for the maiden Bonnie & Clyde drilling…

Emperor signs contract rig for critical Judith-2 gas appraisal well

Emperor Energy is aiming to drill an appraisal well on Judith, the largest undeveloped conventional gas…

Omega Oil & Gas kicks off key new Taroom Trough well at Canyon-4

Omega Oil & Gas has kicked off the next key well aimed at confirming the world-class…